Mackenzie Bean –
Thursday, August 6th, 2020
” Even if this test only spots a fraction of individuals who have early-stage cancer, its the very first time that we will have the ability to detect numerous cancers that are presently lethal when we ought to have the ability to cure them,” Eric Klein, MD, chairman of Cleveland Clinics Glickman Urological & & Kidney Institute who is leading the health systems arm of the research study, said in a news release.
To learn more, click here.
More posts on oncology:14 oncologists on the moveAmerican Cancer Society CEO Gary Reedy to retire8 medical facilities constructing, opening cancer cancers.
Initial outcomes published in March revealed the tests specificity was 99.3 percent. This implies the test has a 0.7 percent incorrect positive rate. The test also accurately identified a cancers location in the body 93 percent of the time.
Cleveland Clinic will evaluate using a blood test that can detect more than 50 cancers as part of a multisite clinical trial, the system stated Aug. 6.
The blood test recognizes DNA that malignant tumors shed into the blood and examines chemical changes to the DNA. The test intends to discover cancer earlier– even before symptoms appear– to enhance clients survival chances..
Preliminary outcomes released in March revealed the tests specificity was 99.3 percent. This indicates the test has a 0.7 percent false favorable rate. The test likewise accurately determined a cancers location in the body 93 percent of the time.
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by click on this link.